Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

Q: What does CUSIP 28036F105 represent in this 13F holders report?

CUSIP 28036F105 is the security identifier for EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q2 2021?

45 institutional investors reported EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 28036F105

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 105,503,387
Total 13F shares: 46,323,514
Share change: +2,195,816
Total reported value: $984,550,000
Price per share: $21.33
Number of holders: 45
Value change: +$40,348,386
Number of buys: 32
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 28036F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	13%	13,944,680	$453,202,000	—	31 Mar 2021	13F
Novo Holdings A/S	13F	Company	5.3%	5,587,207	$181,584,000	—	31 Mar 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	3.7%	3,933,137	$127,827,000	—	31 Mar 2021	13F
VIKING GLOBAL INVESTORS LP	13F	Company	3.2%	3,352,249	$108,948,000	—	31 Mar 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.5%	2,613,623	$84,943,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	2.3%	2,382,148	$77,419,000	—	31 Mar 2021	13F
Cormorant Asset Management, LP	13F	Company	2.2%	2,340,914	$74,307,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	2%	2,140,908	$65,148,000	—	31 Mar 2021	13F
New Leaf Venture Partners, L.L.C.	13F	Company	1.5%	1,553,661	$50,494,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	1.5%	1,530,418	$49,739,000	—	31 Mar 2021	13F
EcoR1 Capital, LLC	13F	Company	1.2%	1,224,175	$39,786,000	—	31 Mar 2021	13F
Logos Global Management LP	13F	Company	1%	1,056,812	$34,346,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.7%	742,412	$23,073,000	—	31 Mar 2021	13F
FEDERATED HERMES, INC.	13F	Company	0.58%	616,724	$20,044,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	0.47%	500,000	$16,250,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.43%	449,000	$14,593,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.34%	357,429	$11,616,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.28%	300,000	$9,750,000	—	31 Mar 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.26%	278,577	$9,054,000	—	31 Mar 2021	13F
Octagon Capital Advisors LP	13F	Company	0.12%	125,000	$4,063,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	0.11%	120,000	$3,900,000	—	31 Mar 2021	13F
Soleus Capital Management, L.P.	13F	Company	0.09%	100,000	$3,250,000	—	31 Mar 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.09%	100,000	$3,250,000	—	31 Mar 2021	13F
CREDIT SUISSE AG/	13F	Company	0.08%	84,052	$2,732,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	65,263	$2,121,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.06%	60,077	$1,953,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.05%	55,485	$1,803,000	—	31 Mar 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.03%	30,000	$975,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	0.02%	20,185	$656,000	—	31 Mar 2021	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.01%	8,923	$290,000	—	31 Mar 2021	13F
Maven Securities LTD	13F	Company	0.01%	8,300	$262,000	—	31 Mar 2021	13F

Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) as of Q2 2021

As of 30 Jun 2021, Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,323,514 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Novo Holdings A/S, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Cormorant Asset Management, LP, VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, FMR LLC, JANUS HENDERSON GROUP PLC, and Logos Global Management LP. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.